Edmund V. Mickunas
General Counsel at Neurotech Pharmaceuticals, Inc. (United States)
Profile
Edmund V.
Mickunas is the founder of Seeing Medicines, Inc. He is currently the Chief Regulatory Officer at Neurotech Pharmaceuticals, Inc. in the United States.
Previously, he held senior positions in regulatory affairs and compliance at Control Delivery Systems, Inc., Beacon Therapeutics (USA), Inc., Oragenics, Inc., and Astellas Institute for Regenerative Medicine.
Mr. Mickunas received his graduate degree from Fairfield University and his undergraduate degree from Fairleigh Dickinson University.
Edmund V. Mickunas active positions
Companies | Position | Start |
---|---|---|
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | General Counsel | - |
Former positions of Edmund V. Mickunas
Companies | Position | End |
---|---|---|
Seeing Medicines, Inc.
Seeing Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Seeing Medicines, Inc. is a preclinical-stage biotechnology company that develops regenerative medicine treatments to restore and maintain vision in people. The company is based in Arden, NC. Seeing Medicines was founded by Lucian Del Priore, Andrew Fowlie, Matthew Vincent, H. LeRoux Jooste, Edmund V. Mickunas. H. LeRoux Jooste has been the CEO since incorporation. | Founder | - |
Control Delivery Systems, Inc.
Control Delivery Systems, Inc. Medical SpecialtiesHealth Technology Control Delivery Systems Inc. designs, develops and manufactures drug delivery products. The products are designed to deliver precise quantities of drugs to difficult-to-treat areas of the body. The company was founded in 1991 and is headquartered in Watertown, MA. | General Counsel | - |
APPLIED GENETIC TECHNOLOGIES CORPORATION | General Counsel | - |
OCATA THERAPEUTICS INC | General Counsel | - |
ORAGENICS, INC. | General Counsel | - |
Training of Edmund V. Mickunas
Fairfield University | Graduate Degree |
Fairleigh Dickinson University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ORAGENICS, INC. | Health Technology |
Private companies | 5 |
---|---|
Control Delivery Systems, Inc.
Control Delivery Systems, Inc. Medical SpecialtiesHealth Technology Control Delivery Systems Inc. designs, develops and manufactures drug delivery products. The products are designed to deliver precise quantities of drugs to difficult-to-treat areas of the body. The company was founded in 1991 and is headquartered in Watertown, MA. | Health Technology |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Health Technology |
Beacon Therapeutics (USA), Inc.
Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
Astellas Institute for Regenerative Medicine
Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
Seeing Medicines, Inc.
Seeing Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Seeing Medicines, Inc. is a preclinical-stage biotechnology company that develops regenerative medicine treatments to restore and maintain vision in people. The company is based in Arden, NC. Seeing Medicines was founded by Lucian Del Priore, Andrew Fowlie, Matthew Vincent, H. LeRoux Jooste, Edmund V. Mickunas. H. LeRoux Jooste has been the CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Edmund V. Mickunas